Headache Care.net

Site updated at Thursday, 02 July 2015

Headache Care

Neurovascular Headache: What Happened to the Blood Vessels?

Wednesday, Apr 15 2009

  

In a study of experimental head pain in which capsaicin was injected into the forehead of volunteers without headache (May et al., 1998b), there was a bilateral activation pattern in midline structures over several planes, slightly lateralized to the left, anterior to the brain stem and posterior to the chiasmatic region. Superimposed on a magnetic resonance imaging template, the location of the activation covers intracranial arteries as well as the region of the cavernous sinus bilaterally but more marked on the ipsilateral side.

Similarly, strong activation was observed in the same region in the cluster headache study (the cavernous sinus) (May et al., 1998a). This change might be interpreted as increased venous inflow from the superior ophthalmic vein, which drains the ophthalmic artery (Waldenlind et al., 1993), or a longer transit time for the tracer in this region, which could be due to impeded venous drainage.

Another, more exciting possibility is that the observed increase in activation is due to bilateral dilation of the internal carotid artery, since such a change would suggest vasodilation mediated by the ophthalmic division of the trigeminovascular system, a neurally driven vasodilation. It is difficult to assess the contribution of these two sources to the activity measured using PET.

To further address this question, magnetic resonance angiography was performed using the same design as the PET study (May et al., 1998a). Using an image calculation tool, the angiographies were subtracted from each other, leaving only structural changes between conditions. It was demonstrated that in the condition nitroglycerine (NTG) inhalation without headache there was dilation of the basilar artery and the internal carotid arteries bilaterally compared to the rest state (May et al., 1999c).

These vessels stayed dilated during the third condition (cluster headache attack), some 20 to 30 minutes later. Given that we have observed vasodilation in large vessels in cluster headache and increased signal in the region of the cavernous sinus after capsaicin injection to the forehead in a PET study (May et al., 1998b), it seems clear that the vascular changes are an epiphenomenon of activation of the trigeminovascular system (Goadsby and Duckworth, 1987) and that cluster headache is not a disorder of the carotid vasculature or cavernous sinus. We have recently seen the very same change in this region in acute migraine studied with PET (Bahra et al., unpublished data).

The data suggest that activation of the trigeminal system, as such, triggers the impeded arterial or venous drainage or increases flow in the region of these vessels. At the physiological level, the common link is the involvement of the ophthalmic division of the trigeminal nerve by a neurally driven dilation of the carotid vessels; on the basis of the data, these headaches should be regarded as neurovascular since vessel change occurs generically with first division of trigeminal pain.

Tension-Type Headache

While most people probably think that they understand tension-type headache (TTH), it seems to the author that this is one of the greatest obstacles to its study. One is generally less questioning about what is true than about what is not thought to be true; TTH implies a process underlying the syndrome, but is this accurate?

The Clinical Problem
Perhaps one of the main stumbling blocks to the study of TTH is the clinical definition. The definition is as much about what TTH is not as what it is. It should not be pulsating, should not be severe, should not be unilateral, should not be aggravated by physical activity, and should have no nausea. It may have photophobia or phonophobia, but not both. Yet are any of these so-called features distinguishing, when they may be seen in migraine. Moreover, chronic TTH offers the possibility of nausea or photophobia or phonophobia but is otherwise phenotypically the same. What is the rationale to allow nausea in chronic TTH but not episodic? What is the possible reason to allow either photophobia or phonophobia in TTH but not both?

There are no answers, and there can be no answers until the study of TTH parcels out all of the features prospectively. The phenotype TTH can probably be produced by a number of biological changes. The fundamental clinical difference between TTH and migraine is that TTH lacks features of sensory sensitivity of any description, so absolutely no nausea and no sensitivity to light, sound, or movement should be permitted; also, it lacks the usual triggering associations of migraine, such as aggravation by menses, skipping meals, or changing sleep patterns. One must ask, how many patients who have contributed to the TTH literature have migrainous biology? This issue must be resolved if we are to understand TTH.

Mechanisms
Given our current knowledge of TTH, it is useful to talk about possible mechanisms rather than identifying one primary factor as causative. It is worth setting out what has been noted as a basis for thinking about the disorder. What follows uses the IHS system, and readers should evaluate the data in light of the clinical remarks above.

Epidemiology and Genetics

The 1-year prevalence of TTH is somewhere between 30% and 80%, most likely on the higher end. In a very thorough general population-based study in Denmark, Rasmussen and colleagues (1991) found a 1-year prevalence of TTH of 69% for men and 88% for women, giving a slight predominance in women. In a telephone-based population sample in the United States, TTH was less common, running at 38% of the population (Schwartz et al., 1998). Chronic TTH is seen in about 2% of the population (Castillo et al., 1999; Scher et al., 1998).

In a general population, most patients with TTH do not consult their physicians (Rasmussen et al., 1992). One study suggests that there are some genetic factors at play in chronic TTH (Ostergaard et al., 1997). Stress is just as often identified as a trigger for migraine as TTH (Scharff et al., 1995) and as such has no diagnostic utility when patients report the symptom.

Muscle Mechanisms
The dull, bilateral, generalized nature of typical TTH provides the impetus to study peripheral sources for the pain. Indeed, TTH has been called “muscle contraction headache.” Injection of saline into cranial muscles certainly induces pain (Kellgren, 1938), and this usually takes 10 to 15 seconds to build up (Jensen and Norup, 1992). Pain from muscle injection is not necessarily restricted to the muscle injected, so injections into the temporalis muscle can cause pain in neck muscles (Simmons et al., 1943). Alogenic substances, such as bradykinin and serotonin, have been injected into human cranial muscles, with minimal pain from the bradykinin and no pain from the serotonin, although together they are more painful than isotonic saline (Jensen et al., 1990). Direct electrical stimulation of muscle causes cramp-like local pain (Laursen et al., 1997), while a combination of chewing and temporal artery ischemia will produce a dull bifrontal headache (Gobel and Cordes, 1990).

Consistent with these observations, pericranial muscles in patients with TTH are more tender than in healthy controls when studied blinded, although this was found mainly for patients with frequent headache of greater than 25 days a month (Langemark and Olesen, 1987). Later studies have shown tenderness in both episodic and chronic TTH (Jensen et al., 1993, 1998).

Pressure pain detection thresholds have been used to study whether this cranial pain is due to some local factor or associated with a more generalized disorder. Pressure pain detection thresholds are normal in episodic TTH (Jensen et al., 1993), whereas they are abnormal in chronic TTH (Bendtsen et al., 1996; Schoenen et al., 1991a). Moreover, patients with chronic TTH are more sensitive to other stimuli, such as thermal stimuli (Langemark et al., 1989). Muscle hardness, which has recently begun to be measured with an ingenious noninvasive technique (Sakai et al., 1995), requires further study. Whether changes represent local pathology or reflexly induced change needs consideration.

Given the very interesting role of nitric oxide generation in spinal cord nociception (Meller and Gebhart, 1993), the recent result of a double-blind study that showed reduction in pain intensity in chronic TTH when the nitric oxide synthase inhibitor L-NG-methylarginine hydrochloride was given (Ashina et al., 1999) suggests a central mechanism for some part of this tenderness.

Neurophysiological Findings

Because muscle contraction has been thought to play a key role in TTH and is indeed enshrined in the current IHS classification, electromyography (EMG) has been of interest in the condition. A review of the data to the mid-1980s (Pikoff, 1984) concluded that in about half of the studies the muscles were normal and in the other half muscular activity was increased. In chronic TTH, EMG activity tends to be higher in patients than controls, but this is unrelated to headache severity or pressure pain thresholds (Schoenen et al., 1991b). Similarly, there is no increase in EMG activity during a headache compared with EMG activity in the absence of a headache (Clark et al., 1995; Jensen, 1995).

Neurophysiological methods have allowed the study of brain stem pathways that have processing functions in headache. The most extensively studied reflex has been that involving exteroceptive suppression produced as a suppression of voluntary masseter and temporalis contraction with electrical stimulation of trigeminal nerve fibers. Exteroceptive suppression is divided into two periods, the early period ES1, mediated by an oligosynaptic pathway, and the late period ES2, mediated by a polysynaptic pathway (Desmedt and Godaux, 1976).

The interneurons responsible for ES2 are likely to be part of the bulbar reticular formation (Hopf, 1994) and receive modulatory projections from limbic structures and the periaqueductal gray matter (Schoenen, 1993b). The ES2 duration is reduced in chronic TTH (Schoenen et al., 1987) but normal in episodic TTH and migraine (Schoenen, 1993a). The conventional blink reflex is normal in TTH (Sand and Zwart, 1994), although the modified nociceptive-specific reflex has not been studied (Kaube et al., 2000). Contingent negative variation, an event-related potential that is recorded over the frontal cortex, is normal in TTH (Schoenen and Timsit-Berthier, 1993).

Given the changes described and the biochemical changes that revolve around central opiate activity (Langemark et al., 1995), its seems that the bulk of the pathophysiological processes in TTH fall within the central nervous system. A vicious cycle of peripheral activation with sensitization and further peripheral activation may underlie some of the muscle observations. Until the clinical material is clarified more closely, our understanding of TTH will progress very slowly.

References

  • Ashina, M., L.H. Lassen, L. Bendtsen, et al. (1999). Effect of inhibition of nitric oxide synthase on chronic tension-type headache. Lancet 353:287 - 289.
  • Bendtsen, L., R. Jensen, and J. Olesen. (1996). Decreased pain detection and tolerance thresholds in chronic tension-type headache. Arch. Neurol. 53:373 - 376.
  • Burstein, R., H. Yamamura, A. Malick et al. (1998). Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J. Neurophysiol. 79:964 - 982.
  • Castillo, J., P. Muqoz, V. Guitera, et al. (1999). Epidemiology of chronic daily headache in the general population. Headache 39:190 - 196.
  • Chazot, G., B. Claustrat, J. Brun et al. (1984). A chronobiological study of melatonin, cortisol, growth hormone and prolactin secretion in cluster headache. Cephalalgia 4:213 - 220.
  • Chudler, E.H. and W.K. Dong. (1995). The role of the basal ganglia in nociception and pain. Pain 60:33 - 38.
  • Clark, G.T., S. Sakai, R. Merrill et al. (1995). Cross-correlation between stress, pain, physical activity, and temporalis muscle EMG in tension-type headache. Cephalalgia 15:511 - 518.
  • Connor, H.E., L. Bertin, S. Gillies et al. (1998). Clinical evaluation of a novel, potent, CNS penetrating NK1 receptor antagonist in the acute treatment of migraine. Cephalalgia 18:392.
  • Cumberbatch, M.J., R.G. Hill, and R.J. Hargreaves. (1997). Rizatriptan has central antinociceptive effects against durally evoked responses. Eur. J. Pharmacol. 328:37 - 40.
  • Cumberbatch, M.J., R.G. Hill, and R.J. Hargreaves. (1998). Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses. Cephalalgia 18:659 - 664.
  • Data, J., K. Britch, N. Westergaard et al. (1998). A double-blind study of ganaxolone in the acute treatment of migraine headaches with or without an aura in premenopausal females. Headache 38:380.
  • Derbyshire, S.W.G., A.K.P. Jones, F. Gyulai et al. (1997). Pain processing during three levels of noxious stimulation produces differential patterns of central activity. Pain 73:431 - 445.
  • Desmedt, J.E. and E. Godaux. (1976). Habituation of exteroceptive suppression and of exteroceptive reflexes in man as influenced by voluntary contraction. Brain Res. 106:21 - 29.
  • Diener, H.C. (1996). Substance-P antagonist RPR100893 - 201 is not effective in human migraine attacks. Proceedings of the VIth International Headache Seminar (J. Olesen and P. Tfelt-Hansen, eds.). Lippincott-Raven, New York.
  • Dimitriadou, V., M.G. Buzzi, M.A. Moskowitz et al. (1991). Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience 44:97 - 112.
  • Drummond, P.D. and J.W. Lance. (1983). Extracranial vascular changes and the source of pain in migraine headache. Ann. Neurol. 13:32 - 37.
  • Earl, N.L., S.A. McDonald, M.T. Lowy, and the 4991W93 Investigator Group. (1999). Efficacy and tolerability of the neurogenic inflammation inhibitor, 4991W93, in the acute treatment of migraine. Cephalalgia 19:357.
  • Ekbom, K. (1968). Nitroglycerin as a provocative agent in cluster headache. Arch. Neurol. 19:487 - 493.
  • Ekbom, K. and T. Greitz. (1970). Carotid angiography in cluster headache. Ada Radiol 10:177 - 186.
  • Fanciullacci, M., M. Alessandri, M. Figini, et al. (1995). Increases in plasma calcitonin gene-related peptide from extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 60:119 - 123.
  • Feindel, W., W. Penfield, and F. McNaughton. (1960). The tentorial nerves and localisation of intracranial pain in man. Neurology 10:555 - 563.
  • Gallai, V, P. Sarchielli, A. Floridi et al. (1995). Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15:384 - 390.
  • Goadsby, P.J. (1998). 5-HT1B/1D agonists in migraine: Comparative pharmacology and its therapeutic implications. CNS Drugs 10:271 - 286.
  • Goadsby, P.J. and J.W. Duckworth. (1987). Effect of stimulation of trigeminal ganglion on regional cerebral blood flow in cats. Am. J. Physiol. 253:R270-R274.
  • Goadsby, P.J. and J.W. Duckworth,. (1989). Low frequency stimulation of the locus coeruleus reduces regional cerebral blood flow in the spinalized cat. Brain Res. 476:71 - 77.
  • Goadsby, P.J. and L. Edvinsson. (1994). Human in vivo evidence for trigeminovascular activation in cluster headache. Brain 117:427 - 434.
  • Goadsby, P.J. and L. Edvinsson,. (1996). Neuropeptide changes in a case of chronic paroxysmal hemicrania -Evidence for trigemino-parasympathetic activation. Cephalalgia 16:448 - 450.
  • Goadsby, P.J., L. Edvinsson, and R. Ekman. (1988). Release of vasoactive peptides in the extracerebral circulation of man and the cat during activation of the trigeminovascular system. Ann. Neurol 23:193 - 196.
  • Goadsby, P.J., L. Edvinsson, and R. Ekman. (1990). Vasoactive peptide release in the extra-cerebral circulation of humans during migraine headache. Ann. Neurol. 28:183 - 187.
  • Goadsby, P.J. and K.L. Hoskin,. (1996). Inhibition of trigeminal neurons by intravenous administration of the serotonin (SHT)-l-D receptor agonist zolmitriptan (311C90): Are brain stem sites a therapeutic target in migraine? Pain 67:355 - 359.
  • Goadsby, P.J. and K.L. Hoskin. (1997). The distribution of trigeminovascular afferents in the non-human primate brain Macaca, nemestrina A c-fos immunocytochemical study. J Anat. 190:367 - 375.
  • Goadsby, P.J., and K.L. Hoskin. (1999). Differential effects of low dose CP122, 288 and eletriptan on Fos expression due to stimulation of the superior sagittal sinus in the cat. Pain 82:15 - 22
  • Goadsby, P. and Y.E. Knight. (1997). Naratriptan inhibits trigeminal neurons after intravenous administration through an action at the serotonin (5HT1B/1D) receptors. Br. J. Pharmacol. 122:918 - 922.
  • Goadsby, P.J., G.A. Lambert, and J.W. Lance,. (1982). Differential effects on the internal and external carotid circulation of the monkey evoked by locus coeruleus stimulation. Brain Res. 249:247 - 254.
  • Goadsby, P.J., G.A. Lambert, and J.W. Lance. (1985). The mechanism of cerebrovascular vasoconstriction in response to locus coeruleus stimulation. Brain Res. 326:213 - 217.
  • Goadsby, P.J. and R.B. Lipton. (1997). A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain 120:193 - 209.
  • Goadsby, P.J. and J. Olesen. (1996). Diagnosis and management of migraine. BMJ 312:1279 - 1282.
  • Goadsby, P.J. and S.D. Silberstein, eds. (1997). Headache. Butterworth-Heinemann, New York.
  • Goadsby, P.J. and A.S. Zagami. (1991). Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat. Brain 114:1001 - 1011.
  • Goadsby, P.J., A.S. Zagami, and G.A. Lambert. (1991). Neural processing of craniovascular pain: A synthesis of the central structures involved in migraine. Headache 31:365 - 371.
  • Gobel, H. and P. Cordes. (1990). Circadian variation of pain sensitivity in pericranial musculature. Headache 30:418 - 422.
  • Goldstein, D.J., O. Wang, J.R. Saper et al. (1997). Ineffectiveness of neurokinin-1 antagonist in acute migraine: A crossover study. Cephalalgia 17:785 - 790.
  • Graham, J.R. and H.G. Wolff. (1938). Mechanism of migraine headache and action of ergotamine tartrate. Arch. Neural. Psychiatry 39:737 - 763.
  • Graham, J.R. and H.G. Wolff,. (1966). Mechanism of migraine headache and action of ergotamine tartrate. In The Circulation of the Brain and Spinal Cord, Vol. 18, pp. 638 - 669. Hafner, New York.
  • Hardebo, J.E. (1994). How cluster headache is explained as an intracavernous inflammatory process lesioning sympathetic fibres. Headache 34:125 - 131.
  • Headache Classification Committee of the International Headache Society. (1988). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl. 7): 1 - 96.
  • Hofman, M.A., J.N. Zhou, and D.F. Swaab. (1996). Suprachiasmatic nucleus of the human brain: An immunocytochemical and morphometric analysis. J Comp. Neurol. 305:552 - 556.
  • Hopf, H.C. (1994). Topodiagnostic value of brain stem reflexes. Muscle Nerv. 17:475 - 484.
  • Hoskin, K.L., H. Kaube, and P.J. Goadsby. (1996). Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine: A c-fos and electrophysiology study. Brain 119:249 - 256.
  • Hoskin, K.L., A. Zagami, and P.J. Goadsby. (1999). Stimulation of die middle meningeal artery leads to bilateral Fos expression in the trigeminocervical nucleus: A comparative study of monkey and cat. J Anat. 194:579 - 588.
  • Hsieh, J.C., J. Hannerz, and M. Ingvar. (1996). Right-lateralized central processing for pain of nitroglycerin-induced cluster headache. Pain 67:59 - 68.
  • Isler, H. (1993). Episodic cluster headache from a textbook of 1745: Van Swieten's classic description. Cephalalgia 13:172 - 174.
  • Jensen, K. and M. Norup. (1992). Experimental pain in human temporal muscle induced by hypertonic saline, potassium and acidity. Cephalalgia 12:101 - 106.
  • Jensen, K., U. Pedersen-Bjergaard, C. Tuxen et al. (1990). Pain and tenderness in human temporal muscle induced by bradykinin and 5-hydroxytryptamine. Peptides 11:1127 - 1132.
  • Jensen, R. (1995). Mechanisms of spontaneous tension-type headache: An analysis of tenderness, pain thresholds and EMG. Pain 64:251.
  • Jensen, R., L. Bendtsen, and J. Olesen,. (1998). Muscular factors are of importance in tension-type headache. Headache 38:10 - 17.
  • Jensen, R., B.K. Rasmussen, B. Pedersen, et al. (1993). Muscle tenderness and pressure pain thresholds in headache: A population study. Pain 52:193 - 199.
  • Kaube, H., K.L. Hoskin, and P.J. Goadsby. (1993a). Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache 33:541 - 550.
  • Kaube, H., K.L. Hoskin, and P.J. Goadsby. (1993b). Sumatriptan inhibits central trigeminal neurons only after blood-brain barrier disruption. Br. J. Pharmacol. 109:788 - 792.
  • Kaube, H., Z. Katsarava, T. Kaufer et al. (2000). A new method to increase the nociception specificity of the human blink reflex. Clin. Neurophysiol 111:413 - 416.
  • Kaube, H., K. Keay, K.L. Hoskin et al. (1993c). Expression of c-fos-like immunoreactivity in the trigeminal nucleus caudalis and high cervical cord following stimulation of the sagittal sinus in the cat. Brain Res. 629:95 - 102.
  • Kellgren, J.H. (1938). Observations on referred pain arising from muscle. Clin. Sci. (Colch.) 3:175 - 190.
  • Knight, Y.E., H.E. Connor, L. Edvinsson et al. (1999a). Only 5HT1B/1D agonist doses of 4991W93 inhibit CGRP release in the cat. Cephalalgia 19:401.
  • Knight, Y.E., L. Edvinsson, and P.J. Goadsby. (1999b). Blockade of CGRP release after superior sagittal sinus stimulation in cat: A comparison of avitriptan and CP122, 288. Neuropeptides 33:41 - 46.
  • Knight, Y.E. and P.J. Goadsby. (1999). Brainstem stimulation inhibits trigeminal neurons in the cat. Cephalalgia 19:315.
  • Kudrow, L. (1976). Plasma testosterone levels in cluster headache preliminary results. Headache 16:228 - 231.
  • Kudrow, L. (1977). Plasma testosterone and LH levels in cluster headache. Headache 17:91 - 92.
  • Lambert, G.A., P.J. Goadsby, A.S. Zagami, et al. (1988). Comparative effects of stimulation of the trigeminal ganglion and the superior sagittal sinus on cerebral blood flow and evoked potentials in the cat. Brain Res. 453:143 - 149.
  • Lance, J.W. and P.J. Goadsby. (1998). Mechanism and Management of Headache, 6th ed. Butter-worth-Heinemann, London.
  • Langemark, M., F.W. Bach, R. Ekman et al. (1995). Increased cerebrospinal fluid metenkephalin immunoreactivity in patients with chronic tension-type headache. Pain 63:103 - 107.
  • Langemark, M., K. Jensen, T.S. Jensen, et al. (1989). Pressure pain thresholds and thermal nociceptive thresholds in chronic tension-type headache. Pain 38:203 - 210.
  • Langemark, M. and J. Olesen,. (1987). Pericranial tenderness in tension headache. A blind, controlled study. Cephalalgia 7:249 - 255.
  • Lassen, L.H., V.B. Jacobsen, P. Petersen, et al. (1998). Human calcitonin gene-related peptide (hCGRP)-induced headache in migraineurs. Eur. J. Neurol. 5(Suppl. 3):S63.
  • Laursen, R.J., T. Graven-Nielsen, T.S. Jensen, et al. (1997). Quantification of local and referred pain in humans by intramuscular electrical stimulation. Eur. J. Pain 1:105 - 113.
  • Leone, M. and G. Bussone. (1993). A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement. Cephalalgia 13:309 - 317.
  • Leone, M., V. Lucini, D. D'Amico, et al. (1995). Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 15:224 - 229.
  • Leone, M., G. Partuno, A. Vescovi et al. (1990). Neuroendocrine dysfunction in cluster headache. Cephalalgia 10:235 - 239.
  • Markowitz, S., K. Saito, and M.A. Moskowitz,. (1987). Neurogenically mediated leakage of plasma proteins occurs from blood vessels in dura mater but not brain. J. Neurosci. 7:4129 - 4136.
  • Martins, I.P., E. Baeta, T. Paiva, et al. (1993). Headaches during intracranial endovascular procedures: A possible model of vascular headache. Headache 33:227 - 233.
  • May, A., J. Ashburner, C. Buchel, et al. (1999a). Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat. Med. 5:836 - 838.
  • May, A., A. Bahra, C. Buchel, et al. (1998a). Hypothalamic activation in cluster headache attacks. Lancet 351:275 - 278.
  • May, A., A. Bahra, C. Buchel et al. (1999b). Functional MRI in spontaneous attacks of SUNCT: Short-lasting neuralgiform headache with conjunctival injection and tearing. Ann. Neurol. 46:791 - 793.
  • May, A., C. Buchel, A. Bahra et al. (1999c). Intracranial vessels in trigeminal transmitted pain: A PET study. Neuroimage 9:453 - 460.
  • May, A., A. Bahra, C. Buchel et al. (2000). PET and MRA findings in cluster headache and MRA in experimental pain. Neurology 55:1328 - 1335.
  • May, A., H.J. Gijsman, A. Wallnoefer et al. (1996). Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks. Pain 67:375 - 378.
  • May, A., H. Kaube, C. Buechel et al. (1998b). Experimental cranial pain elicited by capsaicin: A PET-study. Pain 74:61 - 66.
  • May, A., S. Shepheard, A. Wessing et al. (1998c). Retinal plasma extravasation can be evoked by trigeminal stimulation in rat but does not occur during migraine attacks. Brain 121:1231 - 1237.
  • Meller, S.T. and G.F. Gebhart. (1993). Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52:127 - 136.
  • Moore, R.Y. (1997). Circadian rhythms: Basic neurobiology and clinical applications. Annu. Rev. Med. 48:253 - 266.
  • Moore-Ede, M.C. (1983). The circadian timing system in mammals: Two pacemakers preside over many secondary oscillators. Fed. Proc. 42:2802 - 2808.
  • Moskowitz, M.A., (1988). Cluster headache -Evidence for a pathophysiologic focus in the superior pericarotid cavernous sinus plexus. Headache 25:584 - 586.
  • Moskowitz, M.A. (1990). Basic mechanisms in vascular headache. Neurol. Clin. 8:801 - 815.
  • Moskowitz, M.A. and F.M. Cutrer. (1993). Sumatriptan: A receptor-targeted treatment for migraine. Annu. Rev. Med. 44:145 - 154.
  • Nelson, R.F. (1978). Testosterone levels in cluster and non-cluster migrainous patients. Headache 18:265 - 267.
  • Nichols, F.T., M. Mawad, J.P. Mohr et al. (1993). Focal headache during balloon inflation in the vertebral and basilar arteries. Headache 33:87 - 89.
  • Nichols, F.T., M. Mawad, J.P. Mohr et al. (1990). Focal headache during balloon inflation in the internal carotid and middle cerebral arteries. Stroke 21:555 - 559.
  • Norman, B., D. Panebianco, and G.A. Block. (1998). A placebo-controlled, in clinic study to explore the preliminary safety and efficacy of intravenous L-758, 298 (a prodrug of the NK1 receptor antagonist L-754, 030) in the acute treatment of migraine. Cephalalgia 18:407.
  • Ostergaard, S., M.B. Russell, L. Bendtsen, et al. (1997). Comparison of first degree relatives and spouses of people with chronic tension-type headache. BMJ 314:1092 - 1093.
  • Pikoff, H. (1984). Is the muscular model of headache still viable? A review of conflicting data. Headache 24:186 - 198.
  • Raskin, N.H., Y. Hosobuchi, and S. Lamb. (1987). Headache may arise from perturbation of brain. Headache 27:416 - 420.
  • Rasmussen, B.K. (1995). Epidemiology of headache. Cephalalgia 15:45 - 68.
  • Rasmussen, B.K., R. Jensen, and J. Olesen. (1992). Impact of headache on sickness absence and utilisation of medical services: A Danish population study. J Epidemiol. Community Health 46:443 - 446.
  • Rasmussen, B.K., R. Jensen, and M. Schroll,. (1991). Epidemiology of headache in the general population: A prevalence study. J Clin. Epidemiol. 44:1147 - 1157.
  • Ray, B.S. and H.G. Wolff. (1940). Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch. Surg. 41:813 - 856.
  • Roon, K., H.C. Diener, P. Ellis et al. (1997). CP122, 288 blocks neurogenic inflammation, but is not effective in aborting migraine attacks: Results of two controlled clinical studies. Cephalalgia 17:245.
  • Sakai, F, S. Ebihara, M. Akiyama, et al. (1995). Pericranial muscle hardness in tension-type headache: A non-invasive measurement method and its clinical application. Brain 2:523 - 531.
  • Sand, T. and J.A. Zwart. (1994). The blink reflex in chronic tension-type headache, migraine and cervicogenic headache. Cephalalgia 14:447 - 450.
  • Scharff, L., D.C. Turk, and D.A. Marcus,. (1995). Triggers of headache episodes and coping responses of headache diagnostic groups. Headache 35:397 - 403.
  • Scher, A., W.F. Stewart, J. Liberman, et al. (1998). Prevalence of frequent headache in a population sample. Headache 38:497 - 506.
  • Schoenen, J. (1993a). Exteroceptive suppression of temporalis muscle activity in patients with chronic headache and in normal volunteers: Methodology, clinical and pathophysiological relevance. Headache 33:3 - 17.
  • Schoenen, J. (1993b). Exteroceptive suppression of temporalis muscle activity: Methodological and physiological aspects. Cephalalgia 13:3 - 10.
  • Schoenen, J., D. Bottin, F. Hardy, et al. (1991a). Cephalic and extra-cephalic pressure pain thresholds in chronic tension-type headache. Pain 47:145 - 149.
  • Schoenen, J., P. Gerard, V. De Pasqua, et al. (1991b). Multiple clinical and paraclinical analyses of chronic tension-type headache associated or unassociated with disorder of pericranial muscles. Cephalalgia 11:135 - 139.
  • Schoenen, J., B. Jamart, P. Gerard et al. (1987). Exteroceptive suppression of temporalis muscle activity in chronic headache. Neurology 37:1834 - 1836.
  • Schoenen, J. and M. Timsit-Berthier. (1993). Contingent negative variation: Methods and potential interest in headache. Cephalalgia 13:28 - 32.
  • Schwartz, B.S., W.F. Stewart, D. Simon et al. (1998). Epidemiology of tension-type headache. JAMA 279:381 - 383.
  • Simmons, D.J., E. Day, H. Goodell et al. (1943). Experimental studies on headache: Muscles of the scalp and neck as sources of pain. Assoc. Res. Nerv. Ment. Dis. 23:228 - 244.
  • Stewart, W.F, R.B. Lipton, D.D. Celentano et al. (1992). Prevalence of migraine headache in the United States: Relation to age, income, race and other sociodemographic factors. JAMA 267:64 - 69.
  • Strassman, A.M., S.A. Raymond, and R. Burstein. (1996). Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384:560 - 563.
  • Tunis, M.M. and H.G. Wolff. (1953). Long term observations of the reactivity of the cranial arteries in subjects with vascular headache of the migraine type. Arch. Neurol. Psychiatry 70:551 - 557.
  • Uddman, R., L. Edvinsson, R. Ekman, et al. (1985). Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: Trigeminal origin and co-existence with substance P. Neurosci. Lett. 62:131 - 136.
  • Veloso, F, K. Kumar, and C. Toth. (1998). Headache secondary to deep brain implantation. Headache 38:507 - 515.
  • Waldenlind, E., K. Ekbom, and J. Torhall. (1993). MR-angiography during spontaneous attacks of cluster headache: A case report. Headache 33:291 - 295.
  • Waldenlind, E., S.A. Gustafsson, K. Ekbom et al. (1987). Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J. Neural. Neurosurg. Psychiatry 50:207 - 213.
  • Weiller, C., A. May, V. Limmroth et al. (1995). Brain stem activation in spontaneous human migraine attacks. Nat. Med. 1:658 - 660.
  • Zagami, A.S. and P.J. Goadsby,. (1991). Stimulation of the superior sagittal sinus increases metabolic activity in cat thalamus. In New Advances in Headache Research, Vol. 2 (F.C. Rose, ed.), pp. 169 - 171. Smith-Gordon, London.
  • Zagami, A.S., P.J. Goadsby, and L. Edvinsson. (1990). Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 16:69 - 75.
  • Zagami, A.S. and G.A. Lambert. (1991). Craniovascular application of capsaicin activates nociceptive thalamic neurons in the cat. Neurosci. Lett. 121:187 - 190.

Peter J Goadsby
Editors: Silberstein, Stephen D.; Lipton, Richard B.; Dalessio, Donald J.


This website is certified by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information:

verify here.